50,000 팬데믹 기간 동안 암 진단을 놓칠까봐 두려운 환자

암 시한폭탄: 50,000 환자는 Covid 전염병 동안 진단을 놓칠 우려가 있습니다., 연구 쇼

  • 주위에 50,000 대유행 동안 암 진단을 놓친 환자, 연구 말한다
  • Charity Macmillan claims the figure proves that the NHS is struggling to catch up
  • NHS insists cancer diagnosis and treatment figures back to pre-pandemic levels
  • 그만큼 NHS faces a cancer timebomb because an estimated 50,000 patients have missed out on a diagnosis during the pandemic, a study has revealed.

    Macmillan Cancer Support warned that the health service is ill-equipped to deal with the backlog.

    The charity’s analysis revealed 47,000 fewer people have been diagnosed with cancer in England over the past 18 months than would usually be expected.

    And more than 24,000 who did begin treatment were made to wait too long after diagnosis.

    Macmillan said the figures demonstrate that the NHS is already struggling to keep up with the current number of cancer cases. It said it is ‘deeply concerned’ about how services will cope when the ‘missing’ patients do come forward.

    A study by Macmillan Cancer Support claims that around 50,000 patients have missed out on a diagnosis during the pandemic

    A study by Macmillan Cancer Support claims that around 50,000 patients have missed out on a diagnosis during the pandemic

    Steven McIntosh of Macmillan said: ‘Nearly two years into the pandemic, there is still a mountain of almost 50,000 people who are missing a cancer diagnosis.’

    The NHS said: ‘Cancer diagnosis and treatment numbers have been back at pre-pandemic levels since the spring.’

    Macmillan said the NHS made some progress tackling the cancer backlog over summer but this already appears to have stalled.

    It fears a rise in Covid cases over winter will cause further disruption to cancer services and see the number of missing diagnoses climb further.

    Prostate cancer has seen the biggest fall in diagnoses, with confirmed cases in England down by almost a quarter (23 퍼센트) compared with pre-Covid expectations.

    The next most affected cancer types are multiple myeloma (하위 14 퍼센트), melanoma (13 퍼센트), lymphoid leukaemia (12 퍼센트) and breast cancer (12 퍼센트).

    Macmillan is particularly concerned about breast cancer diagnoses as figures show women are being diagnosed at a later stage, when the disease is harder to treat.

    The number being diagnosed earlyat stage one or twohas been below pre-pandemic levels, while the number being diagnosed at late stage four has been above average.

    Ellen Lang, service manager on the Macmillan Support Line, 말했다: ‘We’re taking an increasing number of calls from people who need help or advice after experiencing a delay to their diagnosis because of issues related to Covid-19 or because they can’t get through to their clinical team to get any of the questions they have answered.

    ‘People are often incredibly distressed about how delays are affecting their prognosis or treatment options, with many feeling like their survival chances are being impacted by the enormous pressures on the NHS.’

    댓글이 닫혀 있습니다..